Global Nevirapine API Market Research Report 2024

Publication ID:

PB506248431

Publication Date:

June 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Nevirapine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nevirapine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nevirapine API.
Report Scope
The Nevirapine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nevirapine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nevirapine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Xinhua Pharmaceutical
ChengDa PharmaCeuticals
Huahai Pharmaceutical
Shanghai Acebright Pharmaceuticals Group Co.,Ltd.
Desano
Anhui Biochem United
Shaoxing Hantai Pharmaceutical Co., Ltd.
Segment by Type
0.98
0.99
Other
Segment by Application
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nevirapine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Nevirapine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Nevirapine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nevirapine API Market Overview
1.1 Product Definition
1.2 Nevirapine API Segment by Type
1.2.1 Global Nevirapine API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 0.98
1.2.3 0.99
1.2.4 Other
1.3 Nevirapine API Segment by Application
1.3.1 Global Nevirapine API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Nevirapine API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Nevirapine API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Nevirapine API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Nevirapine API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nevirapine API Production Market Share by Manufacturers (2019-2024)
2.2 Global Nevirapine API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Nevirapine API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Nevirapine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nevirapine API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Nevirapine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nevirapine API, Product Offered and Application
2.8 Global Key Manufacturers of Nevirapine API, Date of Enter into This Industry
2.9 Nevirapine API Market Competitive Situation and Trends
2.9.1 Nevirapine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nevirapine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nevirapine API Production by Region
3.1 Global Nevirapine API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Nevirapine API Production Value by Region (2019-2030)
3.2.1 Global Nevirapine API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Nevirapine API by Region (2025-2030)
3.3 Global Nevirapine API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Nevirapine API Production by Region (2019-2030)
3.4.1 Global Nevirapine API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Nevirapine API by Region (2025-2030)
3.5 Global Nevirapine API Market Price Analysis by Region (2019-2024)
3.6 Global Nevirapine API Production and Value, Year-over-Year Growth
3.6.1 North America Nevirapine API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Nevirapine API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Nevirapine API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Nevirapine API Production Value Estimates and Forecasts (2019-2030)
4 Nevirapine API Consumption by Region
4.1 Global Nevirapine API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Nevirapine API Consumption by Region (2019-2030)
4.2.1 Global Nevirapine API Consumption by Region (2019-2024)
4.2.2 Global Nevirapine API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Nevirapine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Nevirapine API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nevirapine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Nevirapine API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nevirapine API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Nevirapine API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nevirapine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Nevirapine API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Nevirapine API Production by Type (2019-2030)
5.1.1 Global Nevirapine API Production by Type (2019-2024)
5.1.2 Global Nevirapine API Production by Type (2025-2030)
5.1.3 Global Nevirapine API Production Market Share by Type (2019-2030)
5.2 Global Nevirapine API Production Value by Type (2019-2030)
5.2.1 Global Nevirapine API Production Value by Type (2019-2024)
5.2.2 Global Nevirapine API Production Value by Type (2025-2030)
5.2.3 Global Nevirapine API Production Value Market Share by Type (2019-2030)
5.3 Global Nevirapine API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Nevirapine API Production by Application (2019-2030)
6.1.1 Global Nevirapine API Production by Application (2019-2024)
6.1.2 Global Nevirapine API Production by Application (2025-2030)
6.1.3 Global Nevirapine API Production Market Share by Application (2019-2030)
6.2 Global Nevirapine API Production Value by Application (2019-2030)
6.2.1 Global Nevirapine API Production Value by Application (2019-2024)
6.2.2 Global Nevirapine API Production Value by Application (2025-2030)
6.2.3 Global Nevirapine API Production Value Market Share by Application (2019-2030)
6.3 Global Nevirapine API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Xinhua Pharmaceutical
7.1.1 Xinhua Pharmaceutical Nevirapine API Corporation Information
7.1.2 Xinhua Pharmaceutical Nevirapine API Product Portfolio
7.1.3 Xinhua Pharmaceutical Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Xinhua Pharmaceutical Main Business and Markets Served
7.1.5 Xinhua Pharmaceutical Recent Developments/Updates
7.2 ChengDa PharmaCeuticals
7.2.1 ChengDa PharmaCeuticals Nevirapine API Corporation Information
7.2.2 ChengDa PharmaCeuticals Nevirapine API Product Portfolio
7.2.3 ChengDa PharmaCeuticals Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 ChengDa PharmaCeuticals Main Business and Markets Served
7.2.5 ChengDa PharmaCeuticals Recent Developments/Updates
7.3 Huahai Pharmaceutical
7.3.1 Huahai Pharmaceutical Nevirapine API Corporation Information
7.3.2 Huahai Pharmaceutical Nevirapine API Product Portfolio
7.3.3 Huahai Pharmaceutical Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Huahai Pharmaceutical Main Business and Markets Served
7.3.5 Huahai Pharmaceutical Recent Developments/Updates
7.4 Shanghai Acebright Pharmaceuticals Group Co.,Ltd.
7.4.1 Shanghai Acebright Pharmaceuticals Group Co.,Ltd. Nevirapine API Corporation Information
7.4.2 Shanghai Acebright Pharmaceuticals Group Co.,Ltd. Nevirapine API Product Portfolio
7.4.3 Shanghai Acebright Pharmaceuticals Group Co.,Ltd. Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shanghai Acebright Pharmaceuticals Group Co.,Ltd. Main Business and Markets Served
7.4.5 Shanghai Acebright Pharmaceuticals Group Co.,Ltd. Recent Developments/Updates
7.5 Desano
7.5.1 Desano Nevirapine API Corporation Information
7.5.2 Desano Nevirapine API Product Portfolio
7.5.3 Desano Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Desano Main Business and Markets Served
7.5.5 Desano Recent Developments/Updates
7.6 Anhui Biochem United
7.6.1 Anhui Biochem United Nevirapine API Corporation Information
7.6.2 Anhui Biochem United Nevirapine API Product Portfolio
7.6.3 Anhui Biochem United Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Anhui Biochem United Main Business and Markets Served
7.6.5 Anhui Biochem United Recent Developments/Updates
7.7 Shaoxing Hantai Pharmaceutical Co., Ltd.
7.7.1 Shaoxing Hantai Pharmaceutical Co., Ltd. Nevirapine API Corporation Information
7.7.2 Shaoxing Hantai Pharmaceutical Co., Ltd. Nevirapine API Product Portfolio
7.7.3 Shaoxing Hantai Pharmaceutical Co., Ltd. Nevirapine API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shaoxing Hantai Pharmaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Shaoxing Hantai Pharmaceutical Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nevirapine API Industry Chain Analysis
8.2 Nevirapine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nevirapine API Production Mode & Process
8.4 Nevirapine API Sales and Marketing
8.4.1 Nevirapine API Sales Channels
8.4.2 Nevirapine API Distributors
8.5 Nevirapine API Customers
9 Nevirapine API Market Dynamics
9.1 Nevirapine API Industry Trends
9.2 Nevirapine API Market Drivers
9.3 Nevirapine API Market Challenges
9.4 Nevirapine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Xinhua Pharmaceutical
ChengDa PharmaCeuticals
Huahai Pharmaceutical
Shanghai Acebright Pharmaceuticals Group Co.,Ltd.
Desano
Anhui Biochem United
Shaoxing Hantai Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂